ATE407700T1 - Veränderung der mikrobenflora im verdauungstrakt - Google Patents

Veränderung der mikrobenflora im verdauungstrakt

Info

Publication number
ATE407700T1
ATE407700T1 AT97908076T AT97908076T ATE407700T1 AT E407700 T1 ATE407700 T1 AT E407700T1 AT 97908076 T AT97908076 T AT 97908076T AT 97908076 T AT97908076 T AT 97908076T AT E407700 T1 ATE407700 T1 AT E407700T1
Authority
AT
Austria
Prior art keywords
microogranisms
microbian
flora
change
digestive tract
Prior art date
Application number
AT97908076T
Other languages
English (en)
Inventor
Ian Brown
Patricia Conway
Anthony Evans
Karl Henriksson
Kenneth Mcnaught
Xin Wang
Original Assignee
Univ New South Wales
Burns Philp & Company Ltd
Burns Philp Res & Dev Pty Ltd
Commw Scient Ind Res Org
Arnott S Biscuits Ltd
Gist Brocades Australia Pty Lt
Goodman Fielder Ingredients Lt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPN8812A external-priority patent/AUPN881296A0/en
Priority claimed from AUPN8811A external-priority patent/AUPN881196A0/en
Priority claimed from AUPN8810A external-priority patent/AUPN881096A0/en
Priority claimed from AUPN8814A external-priority patent/AUPN881496A0/en
Application filed by Univ New South Wales, Burns Philp & Company Ltd, Burns Philp Res & Dev Pty Ltd, Commw Scient Ind Res Org, Arnott S Biscuits Ltd, Gist Brocades Australia Pty Lt, Goodman Fielder Ingredients Lt filed Critical Univ New South Wales
Application granted granted Critical
Publication of ATE407700T1 publication Critical patent/ATE407700T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/212—Starch; Modified starch; Starch derivatives, e.g. esters or ethers
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/212—Starch; Modified starch; Starch derivatives, e.g. esters or ethers
    • A23L29/219—Chemically modified starch; Reaction or complexation products of starch with other chemicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Emergency Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT97908076T 1996-03-20 1997-03-20 Veränderung der mikrobenflora im verdauungstrakt ATE407700T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
AUPN8812A AUPN881296A0 (en) 1996-03-20 1996-03-20 Elevation of short chain fatty acids in the gastrointestinal tract
AUPN8811A AUPN881196A0 (en) 1996-03-20 1996-03-20 Alteration of microbial populations in the gastrointestinal tract
AUPN8810A AUPN881096A0 (en) 1996-03-20 1996-03-20 Method of suppressing microbial pathogens
AUPN8814A AUPN881496A0 (en) 1996-03-20 1996-03-20 Attachment of bacteria to starches

Publications (1)

Publication Number Publication Date
ATE407700T1 true ATE407700T1 (de) 2008-09-15

Family

ID=27424409

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97908076T ATE407700T1 (de) 1996-03-20 1997-03-20 Veränderung der mikrobenflora im verdauungstrakt

Country Status (8)

Country Link
US (2) US6348452B1 (de)
EP (1) EP0901371B1 (de)
JP (1) JP4282763B2 (de)
KR (1) KR20000064729A (de)
AT (1) ATE407700T1 (de)
CA (1) CA2249189A1 (de)
DE (1) DE69738975D1 (de)
WO (1) WO1997034591A1 (de)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO824397A0 (en) * 1997-07-25 1997-08-21 Arnott's Biscuits Limited Improved food products
AUPP816899A0 (en) * 1999-01-14 1999-02-11 Food Technology Innovations Pty Limited Improved microbial products
FR2808689B1 (fr) * 2000-05-11 2004-09-03 Agronomique Inst Nat Rech Utilisation de souches acetogenes hydrogenotrophes pour la prevention ou le traitement de troubles digestifs
AUPQ899700A0 (en) 2000-07-25 2000-08-17 Borody, Thomas Julius Probiotic recolonisation therapy
US20050123583A1 (en) * 2000-12-18 2005-06-09 Hsing-Wen Sung Medical use of reuterin
KR100485155B1 (ko) * 2002-05-22 2005-04-22 주식회사 삼양제넥스 효소저항전분을 포함하는 면역활성 증강용 조성물
IL152127A0 (en) * 2002-10-06 2003-05-29 Bio Balance Corp Probiotic compositions for the treatment of inflammatory bowel disease
NZ539900A (en) * 2002-11-07 2008-03-28 Advanced Bionutrition Corp Nutraceuticals and method of feeding aquatic animals
US7252836B2 (en) * 2003-01-13 2007-08-07 Penwest, Ltd. Food and feed compositions including resistant starch
WO2005001098A1 (en) 2003-06-30 2005-01-06 Commonwealth Scientific And Industrial Research Organisation Wheat with altered branching enzyme activity and starch and starch containing products derived thereform
US20060093592A1 (en) * 2004-10-04 2006-05-04 Nutracea Synbiotics
US7189288B2 (en) * 2004-10-08 2007-03-13 Tate & Lyle Ingredients Americas, Inc. Enzyme-resistant starch and method for its production
US12110555B2 (en) 2004-12-08 2024-10-08 Cedars-Sinai Medical Center Diagnosis and treatment of inflammatory bowel disease
US11268149B2 (en) 2004-12-08 2022-03-08 Cedars-Sinai Medical Center Diagnosis and treatment of inflammatory bowel disease
AU2011202664B2 (en) * 2004-12-08 2012-04-05 Cedars-Sinai Medical Center Methods for diagnosis and treatment of Crohn's disease
US10544459B2 (en) 2004-12-08 2020-01-28 Cedars-Sinai Medical Center Methods of using genetic variants for the diagnosis and treatment of inflammatory bowel disease
JP5638736B2 (ja) * 2004-12-30 2014-12-10 コモンウェルス サイエンティフィック アンド インダストリアル リサーチ オーガナイゼーション 腸の健康を改善する方法および手段
US7700139B2 (en) 2004-12-30 2010-04-20 Commonwealth Scientific And Industrial Research Organization Method and means for improving bowel health
US7276126B2 (en) * 2005-06-03 2007-10-02 Tate And Lyle Ingredients Americas, Inc. Production of enzyme-resistant starch by extrusion
US7674897B2 (en) 2005-09-09 2010-03-09 Tate & Lyle Ingredients Americas, Inc. Production of crystalline short chain amylose
EP1981338A2 (de) * 2006-01-13 2008-10-22 Advanced Bionutrition Corporation Produktionssystem mit kontinuierlicher sprühnebelaufnahme
US8057840B2 (en) * 2006-01-25 2011-11-15 Tate & Lyle Ingredients Americas Llc Food products comprising a slowly digestible or digestion resistant carbohydrate composition
US7608436B2 (en) * 2006-01-25 2009-10-27 Tate & Lyle Ingredients Americas, Inc. Process for producing saccharide oligomers
US8993039B2 (en) 2006-01-25 2015-03-31 Tate & Lyle Ingredients Americas Llc Fiber-containing carbohydrate composition
US20080069861A1 (en) * 2006-09-19 2008-03-20 National Starch And Chemical Investment Holding Corporation Probiotic/Non-Probiotic Combinations
DE102006062250A1 (de) * 2006-12-22 2008-06-26 Roland Saur-Brosch Verwendung einer Zusammensetzung aus Mineralstoffen und/oder Vitaminen und gegebenenfalls acetogenen und/oder butyrogenen Bakterien zur oralen oder rektalen Verabreichung für die Behandlung und Vorbeugung von abdominalen Beschwerden
US9603876B2 (en) 2008-09-25 2017-03-28 New York University Compositions and methods for restoring gastrointestinal microbiota following antibiotic treatment
JP2010047606A (ja) * 2009-11-25 2010-03-04 Kao Corp 便秘改善剤
AU2010334993B2 (en) * 2009-12-22 2015-07-09 Probi Ab Non-fermented compositions comprising a cereal based fraction and a probiotic and uses thereof
WO2011151941A1 (ja) 2010-06-04 2011-12-08 国立大学法人東京大学 制御性ｔ細胞の増殖または集積を誘導する作用を有する組成物
US9386793B2 (en) * 2010-08-20 2016-07-12 New York University Compositions and methods for treating obesity and related disorders by characterizing and restoring mammalian bacterial microbiota
CN103491969A (zh) * 2011-02-09 2014-01-01 拉维沃公司 恢复和重建肠道微生物群的合生素组合物
GB201112091D0 (en) 2011-07-14 2011-08-31 Gt Biolog Ltd Bacterial strains isolated from pigs
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
ES2993669T3 (en) 2011-12-01 2025-01-03 Univ Tokyo Human-derived bacteria that induce proliferation or accumulation of regulatory t cells
GB201212588D0 (en) * 2012-07-13 2012-08-29 Univ Glasgow Colicins for treating bacterial infections
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
EP3400953A1 (de) 2014-12-23 2018-11-14 4D Pharma Research Limited Pirinpolypeptid und immunmodulation
AR103260A1 (es) 2014-12-23 2017-04-26 4D Pharma Res Ltd Modulación inmunitaria
SMT201900588T1 (it) 2015-06-15 2019-11-13 4D Pharma Res Limited Blautia stercoris e wexlerae per uso nel trattamento di malattie infiammatorie ed autoimmuni
NZ737752A (en) 2015-06-15 2022-02-25 4D Pharma Res Ltd Compositions comprising bacterial strains
WO2016203221A1 (en) 2015-06-15 2016-12-22 4D Pharma Research Limited Compositions comprising bacterial strains
MA41060B1 (fr) 2015-06-15 2019-11-29 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
MA41010B1 (fr) 2015-06-15 2020-01-31 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
CN108513545B (zh) 2015-11-20 2020-11-03 4D制药研究有限公司 包含细菌菌株的组合物
GB201520497D0 (en) 2015-11-20 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520638D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520631D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
ME03487B (de) 2016-03-04 2020-01-20 4D Pharma Plc Zusammensetzungen mit bakteriellen blautia-stämmen zur behandlung von viszeraler überempfindlichkeit
GB201612191D0 (en) 2016-07-13 2016-08-24 4D Pharma Plc Compositions comprising bacterial strains
WO2017218889A1 (en) * 2016-06-16 2017-12-21 Ohio State Innovation Foundation Eubacterium probiotics and methods of treating or preventing heart disease
TWI802545B (zh) 2016-07-13 2023-05-21 英商４Ｄ製藥有限公司 包含細菌菌株之組合物
US10653728B2 (en) 2016-10-17 2020-05-19 New York University Probiotic compositions for improving metabolism and immunity
GB201621123D0 (en) 2016-12-12 2017-01-25 4D Pharma Plc Compositions comprising bacterial strains
DK3630136T3 (da) 2017-05-22 2021-05-25 4D Pharma Res Ltd Sammensætninger, der omfatter bakteriestammer
EP3630942B1 (de) 2017-05-24 2022-11-30 4D Pharma Research Limited Zusammensetzungen mit bakterienstamm
CA3066189A1 (en) 2017-06-14 2018-12-20 4D Pharma Research Limited Compositions comprising bacterial strains
SMT202000555T1 (it) 2017-06-14 2020-11-10 4D Pharma Res Limited Composizioni comprendenti un ceppo batterico del genere megaspaera e loro usi
SMT202000695T1 (it) 2017-06-14 2021-01-05 4D Pharma Res Limited Composizioni comprendenti ceppi batterici
US11540549B2 (en) 2019-11-28 2023-01-03 Tate & Lyle Solutions Usa Llc High-fiber, low-sugar soluble dietary fibers, products including them and methods for using them

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4112222A (en) * 1977-01-07 1978-09-05 National Starch And Chemical Corp. Method of preparing hydroxypropylated starch derivatives
US5143845A (en) * 1986-09-03 1992-09-01 Toa Pharmaceutical Co., Ltd. Mixture of saccarifying lactic acid producing and butyric acid producing bacteria
DE3727946A1 (de) 1987-08-21 1989-03-02 Werner Georg Munk Rekonstituierbares trockenprodukt zum direktverzehr, verfahren zu seiner herstellung und seine verwendung
AU660560B2 (en) * 1992-07-31 1995-06-29 Corn Products Development, Inc. High amylose starch and resistant starch fractions
US6303174B1 (en) * 1992-12-24 2001-10-16 Goodman Fielder Limited Food compositions including resistant starch
JP3559790B2 (ja) 1993-12-20 2004-09-02 松谷化学工業株式会社 食品にビフィズス菌の増殖促進作用を付与する方法
AUPM823094A0 (en) 1994-09-16 1994-10-13 Goodman Fielder Limited Probiotic compositions
JP3010007B2 (ja) 1995-05-22 2000-02-14 ビオフェルミン製薬株式会社 配合下剤

Also Published As

Publication number Publication date
JP4282763B2 (ja) 2009-06-24
US20080131401A1 (en) 2008-06-05
CA2249189A1 (en) 1997-09-25
JP2001503016A (ja) 2001-03-06
US6348452B1 (en) 2002-02-19
WO1997034591A1 (en) 1997-09-25
EP0901371B1 (de) 2008-09-10
DE69738975D1 (de) 2008-10-23
EP0901371A4 (de) 2004-05-12
EP0901371A1 (de) 1999-03-17
KR20000064729A (ko) 2000-11-06

Similar Documents

Publication Publication Date Title
ATE407700T1 (de) Veränderung der mikrobenflora im verdauungstrakt
EP0910359A4 (de) Selektion und /oder verbesserung der mikrobiellen besiedlung des gastrointestionalen traktes
DK0888118T3 (da) Forögelse af mikrobiel kolonisering af mavetarmkanalen
MXPA01007710A (es) Agente de secado por congelacion que contiene paramilon, su produccion y uso.
TR199700662A3 (tr) Suda eriyen polimerlerin elde edilme prosesi elde edilen polimerler ve kullanimlari.
DE68920223D1 (de) Enzymelektroden und ihre Herstellung.
DE69824550D1 (de) Modifizierte polyester
DE69739558D1 (de) MODIFIZIERTE alpha-AMYLASEN MIT GEÄNDERTEN CALCIUM-BINDENDEN EIGENSCHAFTEN
DE3879118D1 (de) Feuerfestes material, hergestellt aus rotschlamm.
EP1036165A4 (de) Menschliche rnase-h und zusammensetzungen und verwendungen davon
FR2760022B1 (fr) Souche bacterienne marine du genre vibrio, polysaccharides hydrosolubles produits par cette souche, et leurs utilisations
ATE147985T1 (de) Dimeticon-pastillen
RU96122435A (ru) Фрикционное изделие
Part Primate-human conflict
Bringhurst Charles B. Thompson and the Issues of Slavery and Race
Byrd I'm from the Country
KR910012229A (ko) 신규 유산균
Nurse Study on rural development in Barbados
RU96115796A (ru) Перевязочный материал
FR2755142B1 (fr) Souche bacterienne marine du genre alteromonas, exopolysaccharides hydrosolubles produits par cette souche, et leurs utilisations
TH14276A (th) โครงสร้างปลอกกระตุ้นแบบปรุงใหม่
Fraser On the nature and origin of muck deposits, Klondike District, Yukon Territory.
Amit et al. 0 Elsevier Sequoia SA, Lausanne-Printed in the Netherlands
KR900014598A (ko) 변형된 pe_40의 제조
Ruback et al. Evolutionary Violence, Cultural Violence, or Both

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties